Cancer Research Meeting Calendar  Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ambrosone, C. B.
Right arrow Articles by Trovato, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ambrosone, C. B.
Right arrow Articles by Trovato, A.
[Cancer Research 65, 1105-1111, February 1, 2005]
© 2005 American Association for Cancer Research


Epidemiology and Prevention

Polymorphisms in Genes Related to Oxidative Stress (MPO, MnSOD, CAT) and Survival After Treatment for Breast Cancer

Christine B. Ambrosone1, Jiyoung Ahn1,4, Keshav K. Singh2, Hamed Rezaishiraz3, Helena Furberg5, Carol Sweeney6, Brian Coles7 and Andrew Trovato8

Departments of 1 Epidemiology, 2 Cancer Genetics, and 3 Health Behaviors, Roswell Park Cancer Institute, Buffalo, New York; 4 Division of Nutritional Sciences, Cornell University, Ithaca, New York; 5 Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 6 Department of Family and Preventive Medicine, Health Research Center, Salt Lake City, Utah; 7 Division of Molecular Epidemiology, National Center for Toxicological Research, Jefferson, Arkansas; and8 Department of Oncological Sciences, Mount Sinai School of Medicine, New York, New York

Requests for reprints: Christine B. Ambrosone, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263. Phone: 716-845-3082; Fax: 716-845-8487; E-mail: christine.ambrosone{at}roswellpark.org.

The proximate cause of cancer cell death by radiation therapy and a number of therapeutic agents is through generation of reactive oxygen species, resulting in DNA damage as well as mitochondrial membrane disruption, triggering the apoptotic cascade. Because mitochondrial manganese superoxide dismutase catalyzes conversion of superoxide radicals to H2O2, with catalase neutralizing H2O2 and myeloperoxidase converting H2O2 to highly reactive hypochlorous acid, we hypothesized that gene variants could impact the efficacy of treatment for breast cancer and improve survival. Women who were treated with radiation and/or chemotherapy for incident breast cancer at the Arkansas Cancer Research Center from 1985 to 1996 were identified. DNA was extracted from paraffin-embedded normal tissue (n = 279), and MnSOD, CAT, and MPO genotypes were determined using mass spectrometry. Cox proportional hazards models were adjusted for age, race, stage with node status, and estrogen receptor and progesterone receptor status. Women who were homozygous for MPO G alleles, associated with increased transcription, had better survival (hazard ratio, 0.60; 95% confidence interval, 0.38-0.95; P = 0.03) than those with common alleles. Both CAT TT and MnSOD CC genotypes were associated with nonsignificant reduced hazard of death. When we combined genotypes associated with higher levels of reactive oxygen species for MnSOD and MPO, women with MnSOD CC and MPO GG genotypes had a 3-fold decrease in hazard of death (hazard ratio, 0.33; 95% confidence interval, 0.13-0.80; P = 0.01). These data indicate that gene variants that impact oxidative stress modify prognosis after treatment for breast cancer.

Key Words: breast cancer • survival • reactive oxygen species • polymorphism




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
S. A. Glynn, B. J. Boersma, T. M. Howe, H. Edvardsen, S. B. Geisler, J. E. Goodman, L. A. Ridnour, P. E. Lonning, A.-L. Borresen-Dale, B. Naume, et al.
A Mitochondrial Target Sequence Polymorphism in Manganese Superoxide Dismutase Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide
Clin. Cancer Res., June 15, 2009; 15(12): 4165 - 4173.
[Abstract] [Full Text] [PDF]


Home page
In VivoHome page
T. IGUCHI, S. SUGITA, C. Y. WANG, N. B. NEWMAN, T. NAKATANI, and G. P. HAAS
MnSOD Genotype and Prostate Cancer Risk as a Function of NAT Genotype and Smoking Status
In Vivo, January 1, 2009; 23(1): 7 - 12.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S.-H. Tan, S.-C. Lee, B.-C. Goh, and J. Wong
Pharmacogenetics in Breast Cancer Therapy
Clin. Cancer Res., December 15, 2008; 14(24): 8027 - 8041.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Bag and N. Bag
Target Sequence Polymorphism of Human Manganese Superoxide Dismutase Gene and Its Association with Cancer Risk: A Review
Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3298 - 3305.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
B. D. Lawenda, K. M. Kelly, E. J. Ladas, S. M. Sagar, A. Vickers, and J. B. Blumberg
Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy?
J Natl Cancer Inst, June 4, 2008; 100(11): 773 - 783.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J.-Y. Choi, M. L. Neuhouser, M. J. Barnett, C.-C. Hong, A. R. Kristal, M. D. Thornquist, I. B. King, G. E. Goodman, and C. B. Ambrosone
Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort
Carcinogenesis, May 1, 2008; 29(5): 964 - 970.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Udler, A.-T. Maia, A. Cebrian, C. Brown, D. Greenberg, M. Shah, C. Caldas, A. Dunning, D. Easton, B. Ponder, et al.
Common Germline Genetic Variation in Antioxidant Defense Genes and Survival After Diagnosis of Breast Cancer
J. Clin. Oncol., July 20, 2007; 25(21): 3015 - 3023.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J.-Y. Choi, M. L. Neuhouser, M. Barnett, M. Hudson, A. R. Kristal, M. Thornquist, I. B. King, G. E. Goodman, and C. B. Ambrosone
Polymorphisms in Oxidative Stress-Related Genes Are Not Associated with Prostate Cancer Risk in Heavy Smokers
Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1115 - 1120.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. J. Gillies and E. S. Krul
Using Genetic Variation to Optimize Nutritional Preemption
J. Nutr., January 1, 2007; 137(1): 270S - 274S.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Ahn, C. B. Ambrosone, P. A. Kanetsky, C. Tian, T. A. Lehman, S. Kropp, I. Helmbold, D. von Fournier, W. Haase, M. L. Sautter-Bihl, et al.
Polymorphisms in Genes Related to Oxidative Stress (CAT, MnSOD, MPO, and eNOS) and Acute Toxicities from Radiation Therapy following Lumpectomy for Breast Cancer
Clin. Cancer Res., December 1, 2006; 12(23): 7063 - 7070.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. S. Wang, S. Davis, J. R. Cerhan, P. Hartge, R. K. Severson, W. Cozen, Q. Lan, R. Welch, S. J. Chanock, and N. Rothman
Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma
Carcinogenesis, September 1, 2006; 27(9): 1828 - 1834.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.